Abbott will gain an innovative, complementary solution in treating vascular disease through CSI's leading atherectomy system, which prepares vessels for angioplasty or stenting to restore blood flow ...

Abbott Laboratories, Inc. ABT recently entered into a definitive agreement to acquire Cardiovascular Systems CSII-- a medical device company with an innovative atherectomy system. The deal will help ...

Cardiovascular disease is rising, presenting an opportunity for investors; Abbott Laboratories is well-positioned in the CVD treatment space to benefit from this trend. Abbott's recent double-digit ...

Abbott Laboratories announced it will acquire Cardiovascular Systems, Inc. (CSI) for $890 million Thursday morning. CSI is a medical device company based in St. Paul, Minnesota that manufactures ...

Abbott has agreed to acquire Cardiovascular Systems, a company that has long been considered one of the most attractive medtech M&A targets. But the pending acquisition is just one of a flurry of ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott already churns out a variety of catheters, stents, imaging systems and other technologies used to remove plaque buildups from blood vessels and keep the blood flowing through the newly cleaned ...

Abbott Laboratories plans to acquire medical-device company Cardiovascular Systems Inc. in a deal that will boost Abbott’s vascular disease offerings. Under the terms, Cardiovascular Systems ...

Abbott Laboratories has scored an FDA approval for its Tendyne transcatheter mitral valve repair (TMVR) system. The nod from FDA comes a little more than a month after Edwards Lifesciences, Abbott’s ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal for Minnesota-based ...

Illinois-based medical technology giant Abbott will acquire New Brighton-based medical device company Cardiovascular Systems Inc., the companies announced Wednesday. Under the terms of the agreement, ...